Flex Biomedical

Flex Biomedical, headquartered in Madison and founded in 2007, is currently dedicated to developing innovative therapies for orthopedic conditions. The company's lead product, Flex Polymer, is a synthetic polymer designed to treat osteoarthritis, an incurable and debilitating joint disease that affects 27 million people in the United States and 100 million worldwide.